2016
DOI: 10.1021/acschembio.6b00173
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Tumor Cells by Natural Anti-Carbohydrate Antibodies Using Rhamnose-Functionalized Liposomes

Abstract: Recruitment of antibodies in human immune systems for targeted destruction of tumor cells has emerged as an exciting area of research due to its low occurrence of side effects, high efficacy, and high specificity. The presence of large amounts of anticarbohydrate natural antibodies in human sera has prompted research efforts to utilize carbohydrate epitopes for immune recruitment. Here, we have developed a general strategy for specific targeted destruction of tumor cells based on rhamnose-functionalized liposo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
35
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(35 citation statements)
references
References 16 publications
0
35
0
Order By: Relevance
“…By the PEG approach, surface-surface interactions including the aggregation of liposomes and/or adsorption of plasma proteins are reduced [ 13 ] but not totally prevented [ 14 ]. More recently, with the main aim of effectively delivering drugs and improving their therapeutic index and reducing their undesired side effects, liposomes have been tailored by attaching particular components to the outer part of the bilayer like peptides [ 15 , 16 , 17 ] to reach specific targets such as cancer or malaria-infected cells [ 18 , 19 , 20 ]. Among the peptides, the Arginine-Glycine-Aspartate (RGD) triad has been often selected as nanoparticles scaffold for displaying a strong affinity and selectivity to the α V β 3 integrin that is overexpressed in malignant tissues.…”
Section: Introductionmentioning
confidence: 99%
“…By the PEG approach, surface-surface interactions including the aggregation of liposomes and/or adsorption of plasma proteins are reduced [ 13 ] but not totally prevented [ 14 ]. More recently, with the main aim of effectively delivering drugs and improving their therapeutic index and reducing their undesired side effects, liposomes have been tailored by attaching particular components to the outer part of the bilayer like peptides [ 15 , 16 , 17 ] to reach specific targets such as cancer or malaria-infected cells [ 18 , 19 , 20 ]. Among the peptides, the Arginine-Glycine-Aspartate (RGD) triad has been often selected as nanoparticles scaffold for displaying a strong affinity and selectivity to the α V β 3 integrin that is overexpressed in malignant tissues.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, as shown in Figure 5, liposomes (FA/rha 1 : 2500) were able to significantly delay tumor growth with minimal toxicity in rhamnose immunized mice, thereby demonstrating the therapeutic benefits of this approach. [61] Recently, the De Geest group published several papers on so-called antibody recruiting polymers (ARPs) in the context of cancer immunotherapy. The first question that was addressed is to what extent polymeric scaffolds that contain multiple antibody-recruiting hapten motifs allow for a more efficient antibody recruitment to the cell surface with prolonged cell surface persistence and efficient induction of innate effector killing.…”
Section: Multivalent Antibody-recruiting Macromoleculesmentioning
confidence: 99%
“…[4,10,11] Another example is the exploitation of the abundance of the circulating anti-L-rhamnose antibodies in human blood, [12,13] that can be recruited using multivalent rhamnose conjugates. [14][15][16][17][18] We reasoned that the development of automated solid phase techniques to generate clusters of (different) carbohydrates would be attractive to rapidly assemble multivalent glycoconjugates. [6] Ponader et al developed a solid-phase synthesis method to obtain homo-and hetero-multivalent glycooligomers using alkyne-functionalized building blocks functionalized by a Cu-catalyzed azide-alkyne [2+3] cycloaddition with mannose, galactose or glucose synthons equipped with an azide.…”
Section: Introductionmentioning
confidence: 99%